| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $20.0M | -13.7% |
| Cost of Revenue | $11.4M | -14.2% |
| Gross Profit | $8.5M | -13.1% |
| R&D Expense | $4K | +418.5% |
| SG&A Expense | $10.5M | -5.3% |
| Operating Income | -$2.0M | +46.9% |
| Pre-tax Income | -$2.3M | +81.5% |
| Income Tax | $2.1M | -3.3% |
| Net Income | -$4.5M | +67.5% |
| EPS (Basic) | -$0.05 | +78.3% |
| EPS (Diluted) | -$0.05 | +78.3% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $600K | -39.9% |
| Accounts Receivable | $683K | +58.4% |
| Inventory | $2.0M | -34.7% |
| Current Assets | $3.3M | -28.1% |
| Total Assets | $7.9M | -21.3% |
| Current Liabilities | $14.2M | -12.9% |
| Long-term Debt | $6.8M | -43.2% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $809K | +451.8% |
| Capital Expenditures | $148K | -2.7% |
| Investing Cash Flow | -$148K | -36.8% |
| Financing Cash Flow | -$1.1M | +12.9% |
| Free Cash Flow | $661K | +272.9% |
| Total Liabilities |
| $20.8M |
| -12.7% |
| Stockholders' Equity | -$11.8M | +7.0% |